TriSalus Life Sciences, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $17.00K, a 69.64% decline year-over-year.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $32.00K, a 88.53% decline year-over-year.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $88.00K, a 4300.00% increase year-over-year.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $56.00K, a 1020.00% increase year-over-year.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $510.00K, a 571.05% increase from fiscal 2024.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $76.00K, a 57.78% decline from fiscal 2023.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $180.00K, a 91.49% increase from fiscal 2022.
- TriSalus Life Sciences, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $94.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $17.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $32.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $510.00K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $88.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $56.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $279.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $76.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $2.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $5.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $7.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $180.00K 10-K/A · filed 2025-05-30 | |
| 2023-09-30 | $29.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $16.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $50.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $94.00K 10-K · filed 2024-04-11 | |
| 2022-09-30 | $7.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $5.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $61.00K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |